Live-donor nephrectomy

Juan P. Rocca, Eric Davis, Michael Edye

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Six decades after its first implementation, kidney transplantation remains the optimal therapy for end-stage renal disease requiring dialysis. Despite the incontrovertible mortality reduction and cost-effectiveness of kidney transplantation, the greatest remaining barrier to treatment of end-stage renal disease is organ availability. Although the waiting list of patients who stand to benefit from kidney transplantation grows at a rate proportional to the overall population and proliferation of diabetes and hypertension, the pool of deceased-donor organs available for transplantation experiences minimal to no growth. Because the kidney is uniquely suited as a paired organ, the transplant community's answer to this shortage is living donation of a healthy volunteer's kidney to a recipient with end-stage renal disease. This review details the history and evolution of living-donor kidney transplantation in the United States as well as advances the next decade promises. Laparoscopic donor nephrectomy has overcome many of the obstacles to living donation in terms of donor morbidity and volunteerism. Knowndonor risks in terms of surgical and medical morbidity are reviewed, as well as the ongoing efforts to delineate and mitigate donor risk in the context of accumulating recipient morbidity while on the waiting list.

Original languageEnglish (US)
Pages (from-to)330-341
Number of pages12
JournalMount Sinai Journal of Medicine
Volume79
Issue number3
DOIs
StatePublished - May 2012
Externally publishedYes

Fingerprint

Nephrectomy
Kidney Transplantation
Tissue Donors
Chronic Kidney Failure
Waiting Lists
Morbidity
Kidney
Living Donors
Organ Transplantation
Cost-Benefit Analysis
Dialysis
Volunteers
Healthy Volunteers
History
Hypertension
Transplants
Mortality
Therapeutics
Growth
Population

Keywords

  • Kidney transplantation
  • Laparoscopic donor nephrectomy
  • Living kidney donor
  • Organ availability

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Live-donor nephrectomy. / Rocca, Juan P.; Davis, Eric; Edye, Michael.

In: Mount Sinai Journal of Medicine, Vol. 79, No. 3, 05.2012, p. 330-341.

Research output: Contribution to journalArticle

Rocca, Juan P. ; Davis, Eric ; Edye, Michael. / Live-donor nephrectomy. In: Mount Sinai Journal of Medicine. 2012 ; Vol. 79, No. 3. pp. 330-341.
@article{f13ce2d3312348ebad5555da7f32500e,
title = "Live-donor nephrectomy",
abstract = "Six decades after its first implementation, kidney transplantation remains the optimal therapy for end-stage renal disease requiring dialysis. Despite the incontrovertible mortality reduction and cost-effectiveness of kidney transplantation, the greatest remaining barrier to treatment of end-stage renal disease is organ availability. Although the waiting list of patients who stand to benefit from kidney transplantation grows at a rate proportional to the overall population and proliferation of diabetes and hypertension, the pool of deceased-donor organs available for transplantation experiences minimal to no growth. Because the kidney is uniquely suited as a paired organ, the transplant community's answer to this shortage is living donation of a healthy volunteer's kidney to a recipient with end-stage renal disease. This review details the history and evolution of living-donor kidney transplantation in the United States as well as advances the next decade promises. Laparoscopic donor nephrectomy has overcome many of the obstacles to living donation in terms of donor morbidity and volunteerism. Knowndonor risks in terms of surgical and medical morbidity are reviewed, as well as the ongoing efforts to delineate and mitigate donor risk in the context of accumulating recipient morbidity while on the waiting list.",
keywords = "Kidney transplantation, Laparoscopic donor nephrectomy, Living kidney donor, Organ availability",
author = "Rocca, {Juan P.} and Eric Davis and Michael Edye",
year = "2012",
month = "5",
doi = "10.1002/msj.21317",
language = "English (US)",
volume = "79",
pages = "330--341",
journal = "Annals of Global Health",
issn = "0027-2507",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Live-donor nephrectomy

AU - Rocca, Juan P.

AU - Davis, Eric

AU - Edye, Michael

PY - 2012/5

Y1 - 2012/5

N2 - Six decades after its first implementation, kidney transplantation remains the optimal therapy for end-stage renal disease requiring dialysis. Despite the incontrovertible mortality reduction and cost-effectiveness of kidney transplantation, the greatest remaining barrier to treatment of end-stage renal disease is organ availability. Although the waiting list of patients who stand to benefit from kidney transplantation grows at a rate proportional to the overall population and proliferation of diabetes and hypertension, the pool of deceased-donor organs available for transplantation experiences minimal to no growth. Because the kidney is uniquely suited as a paired organ, the transplant community's answer to this shortage is living donation of a healthy volunteer's kidney to a recipient with end-stage renal disease. This review details the history and evolution of living-donor kidney transplantation in the United States as well as advances the next decade promises. Laparoscopic donor nephrectomy has overcome many of the obstacles to living donation in terms of donor morbidity and volunteerism. Knowndonor risks in terms of surgical and medical morbidity are reviewed, as well as the ongoing efforts to delineate and mitigate donor risk in the context of accumulating recipient morbidity while on the waiting list.

AB - Six decades after its first implementation, kidney transplantation remains the optimal therapy for end-stage renal disease requiring dialysis. Despite the incontrovertible mortality reduction and cost-effectiveness of kidney transplantation, the greatest remaining barrier to treatment of end-stage renal disease is organ availability. Although the waiting list of patients who stand to benefit from kidney transplantation grows at a rate proportional to the overall population and proliferation of diabetes and hypertension, the pool of deceased-donor organs available for transplantation experiences minimal to no growth. Because the kidney is uniquely suited as a paired organ, the transplant community's answer to this shortage is living donation of a healthy volunteer's kidney to a recipient with end-stage renal disease. This review details the history and evolution of living-donor kidney transplantation in the United States as well as advances the next decade promises. Laparoscopic donor nephrectomy has overcome many of the obstacles to living donation in terms of donor morbidity and volunteerism. Knowndonor risks in terms of surgical and medical morbidity are reviewed, as well as the ongoing efforts to delineate and mitigate donor risk in the context of accumulating recipient morbidity while on the waiting list.

KW - Kidney transplantation

KW - Laparoscopic donor nephrectomy

KW - Living kidney donor

KW - Organ availability

UR - http://www.scopus.com/inward/record.url?scp=84862193032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862193032&partnerID=8YFLogxK

U2 - 10.1002/msj.21317

DO - 10.1002/msj.21317

M3 - Article

VL - 79

SP - 330

EP - 341

JO - Annals of Global Health

JF - Annals of Global Health

SN - 0027-2507

IS - 3

ER -